HomeConditionsSoft Tissue Sarcoma

Soft Tissue Sarcoma

Soft tissue sarcoma is a rare cancer that affects the soft tissues of the body. It can arise from various types of tissue and is more common in adults. The causes are not fully understood, but certain risk factors have been identified. Symptoms include lumps, pain, limited mobility, fatigue, and weight loss. Diagnosis involves physical examination and imaging, with a biopsy confirming the diagnosis. Treatment options include surgery, radiation therapy, and chemotherapy. Prognosis varies depending on the tumor characteristics. Early detection

Best medications for Soft Tissue Sarcoma

Drug NameClassRouteStandard DosagePrice
GleevecKinase InhibitorsOral400, 100 MGfrom$28.74
VotrientKinase InhibitorsOral200 MGfrom$1252.64
TazverikNucleoside Metabolic InhibitorsOral200 MGfrom$2543.17


Soft tissue sarcoma refers to a group of rare cancers that develop in the soft tissues of the body. These tumors can arise from various types of soft tissue, including muscles, tendons, fat, blood vessels, nerves, and deep skin tissues. Soft tissue sarcoma can occur at any age, but it is more commonly diagnosed in adults. This article provides an overview of soft tissue sarcoma, including its causes, symptoms, diagnosis, treatment options, and prognosis.


The exact causes of soft tissue sarcoma are not yet fully understood. However, certain risk factors have been identified, including exposure to high levels of radiation, certain genetic conditions (such as neurofibromatosis and Li-Fraumeni syndrome), and prior treatment with certain chemotherapy drugs (such as doxorubicin and dacarbazine).


Soft tissue sarcoma can present with a variety of symptoms. In some cases, a lump or swelling may be observed at the site of the tumor. Other common symptoms include pain, limited mobility or stiffness in the affected area, fatigue, weight loss, and occasionally, a feeling of fullness or pressure in the abdomen if the tumor is located in the abdominal region.


To diagnose soft tissue sarcoma, a thorough evaluation is required. This typically involves a physical examination, review of medical history, and imaging techniques such as X-ray, MRI, or CT scan. A biopsy, which involves the removal of a small sample of tissue from the tumor, is necessary to confirm the diagnosis and determine the specific type and grade of sarcoma.


The treatment of soft tissue sarcoma depends on several factors, including the type, size, grade, and stage of the tumor, as well as the patient's overall health and preferences. Treatment options include surgery, radiation therapy, and chemotherapy. Surgery is often the primary treatment approach and involves the removal of the tumor along with some surrounding healthy tissue. In cases where surgery is not feasible, radiation therapy and chemotherapy may be used to shrink the tumor or control its growth.


The prognosis for soft tissue sarcoma varies depending on several factors. Generally, early-stage tumors that can be completely removed through surgery tend to have a better prognosis. However, the chances of recurrence and metastasis (spread to distant organs) can still exist. The five-year survival rate for soft tissue sarcoma ranges from 50% to 80%, with factors such as tumor size, location, and grade influencing the outcome.


Soft tissue sarcoma is a rare form of cancer that originates in the soft tissues of the body. While the exact causes remain unknown, several risk factors have been identified. Prompt diagnosis and treatment are crucial in improving the chances of a favorable outcome. If you experience any unusual lumps, persistent pain, or other concerning symptoms, it is important to consult a healthcare professional for further evaluation and guidance.